Skip to main content
Cancer Explained

In memory

Remembering Minnie Riperton: A Voice That Changed How We Talk About Breast Cancer

The 'Lovin' You' singer died of breast cancer at 31 — after becoming one of the first celebrities to share her diagnosis openly with the world.

Please note: this page is educational only — it is not medical advice, and it does not speculate about anyone’s health beyond reliable public reporting. For questions about your own health, talk with your healthcare team.

The news

Minnie Riperton — the singer whose five-octave range made "Lovin' You" unforgettable — died of breast cancer on July 12, 1979, in Los Angeles. She was 31 years old.

What set Riperton's story apart was her openness in an era of silence. Diagnosed in 1976, she underwent a mastectomy and then did something almost no public figure did at the time: she talked about it, revealing her diagnosis and surgery on The Tonight Show that same year. By her own public account, the cancer had already spread by the time it was found. She became a spokesperson for the American Cancer Society, received its Courage Award at the White House in 1978, and kept performing almost until the end of her life.

Why people are talking about it

Decades on, Riperton is remembered not only for her voice — sampled and covered by generations of artists — but as a pioneer of speaking publicly about breast cancer, particularly as a young Black woman at a time when the disease was barely discussed at all. The awareness culture we now take for granted owes something real to people like her, who chose honesty when it was hard.

What this cancer means

According to the National Cancer Institute, breast cancer is the second most common cancer in women after skin cancer. It begins when breast cells grow out of control, and it can occur at any adult age — Riperton's diagnosis at 28 is a reminder that, while risk rises with age, younger women are not immune.

Her publicly shared situation — cancer that had already spread beyond the breast when found — is what NCI calls metastatic cancer: cancer that has traveled from where it started to other parts of the body. NCI explains that metastatic breast cancer is still breast cancer, named and treated for where it began, not where it spread.

Awareness, screening & prevention

The landscape has changed profoundly since 1979. NCI states that mammograms can detect breast cancer early, possibly before it has spread — the very thing that was not possible for so many women of Riperton's generation. When to start and how often to screen depends on your age and risk; you can learn more about mammograms, and our free screening check-up tool can show which screenings are generally recommended at your age.

Just as important is the habit Riperton's openness encouraged: knowing your own body, noticing changes in how your breasts look or feel, and bringing changes to a doctor promptly — at any age.

Common questions

Can women in their twenties really get breast cancer? Yes. It is less common in younger women, but it happens — Riperton was 28 at diagnosis. Changes in the breast deserve medical attention at any age.

What does "the cancer had spread" mean? NCI calls this metastasis: cancer cells traveling from the original tumor to other parts of the body. Cancer found before it spreads is generally easier to treat, which is the core logic of screening and early attention to symptoms.

What made her story so important? Visibility. She put a beloved, young, vibrant face on a disease people whispered about — and made it easier for the next person to speak up, get checked, and ask questions.

Questions to ask a healthcare team

  • Given my age and family history, when should breast cancer screening start for me?
  • What breast changes should I report right away?
  • Does breast cancer in my family mean I should consider genetic counseling?
  • How do I do a good job of knowing what's normal for my body?

Go deeper with NCI

💛 Support free cancer education

Cancer Explained is free for everyone. Donations help us keep creating calm, plain-language explanations based on trusted National Cancer Institute resources.